FSCAX
Price
$30.57
Change
+$0.03 (+0.10%)
Updated
Jun 30 closing price
Net Assets
270.31M
VISVX
Price
$46.77
Change
-$0.19 (-0.40%)
Updated
Jun 30 closing price
Net Assets
54.02B
Interact to see
Advertisement

FSCAX vs VISVX

Header iconFSCAX vs VISVX Comparison
Open Charts FSCAX vs VISVXBanner chart's image
Nuveen Small Cap Value A
Price$30.57
Change+$0.03 (+0.10%)
VolumeN/A
Net Assets270.31M
Vanguard Small Cap Value Index I
Price$46.77
Change-$0.19 (-0.40%)
VolumeN/A
Net Assets54.02B
FSCAX vs VISVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSCAX vs. VISVX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCAX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 54B vs. FSCAX (270M). VISVX pays higher dividends than FSCAX: VISVX (2.11) vs FSCAX (1.38). FSCAX was incepted earlier than VISVX: FSCAX (31 years) vs VISVX (27 years). FSCAX (1.31) is less costly to investors than VISVX (0.19). FSCAX is a more actively managed with annual turnover of: 23.00 vs. VISVX (16.00). FSCAX (3000) and VISVX (3000) have matching initial minimum investment requirements. VISVX annual gain was more profitable for investors over the last year : 7.72 vs. FSCAX (6.81). FSCAX return over 5 years is better than : 97.33 vs. VISVX (88.95).
FSCAXVISVXFSCAX / VISVX
Total Expense Ratio1.200.19632%
Annual Report Gross Expense Ratio1.310.19689%
Fund Existence31 years27 years-
Gain YTD-2.955-1.066277%
Front Load6%N/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets270M54B1%
Annual Yield % from dividends1.382.1165%
Returns for 1 year6.817.7288%
Returns for 3 years25.8730.6884%
Returns for 5 years97.3388.95109%
Returns for 10 years59.2889.5966%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCSA0.200.01
+4.49%
Processa Pharmaceuticals
SYNA64.820.04
+0.06%
Synaptics
HTHT33.92-0.31
-0.91%
H World Group Limited
UVSP30.04-0.58
-1.89%
Univest Financial Corp
PLX1.48-0.06
-3.90%
Protalix BioTherapeutics